APRE · Categories · Form 3

APRE - SEC Form 3 initial insider statements

Aprea Therapeutics Inc. (APRE) sec form 3 initial insider statements - real-time wire coverage filtered to Form 3 only.

Recent Form 3 for APRE

• 769d
  SEC Form 3 filed by new insider Mirza Nadeem Q.

  3 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1021d
  SEC Form 3 filed by new insider Bizzari Jean-Pierre

  3 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1129d
  SEC Form 3 filed by new insider Gruia Gabriela

  3 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1227d
  SEC Form 3 filed by new insider Hamill John P.

  3 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1476d
  SEC Form 3 filed by new insider Grissinger Michael

  3 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1476d
  SEC Form 3: New insider Gilad Oren claimed ownership of 229,014 shares

  3 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1476d
  SEC Form 3: New insider Pamukcu Rifat claimed ownership of 12,166 shares

  3 - Aprea Therapeutics, Inc. (0001781983) (Issuer)
• 1476d
  SEC Form 3: New insider Duey Marc claimed ownership of 152,343 shares

  3 - Aprea Therapeutics, Inc. (0001781983) (Issuer)

Other APRE categories

• 8-K
• 10-K
• 10-Q
• S-1
• 13D
• 13G
• Form 4
• Form 5
• DEF 14A
• M&A
• Earnings
• Dividends